Mettrum™ set for expansive growth as it continues to focus on Canadian healthcare practitioners and patients

To download b-roll video footage associated with this release please visit: http://www.multivu.com/players/English/7601551-cnw-vod/

TORONTO, Aug. 17, 2015 /CNW/ - Mettrum Health Corp. (Mettrum™) (TSXV:MT) (TSXV:MT.WT), a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of Health Canada licensed cannabis products, has made educating and resourcing healthcare practitioners and their patients across Canada a top priority, resulting in continued industry leadership and strong company growth. Reported on August 12, 2015, the company achieved a 20 per cent increase in the number of Mettrum registered clients and a 47 per cent increase in revenue for the first quarter fiscal 2016 financial results for the period ended June 30, 2015 compared to the previous quarter.

Mettrum is one of Canada's first licensed producers, receiving its license from Health Canada on November 1, 2013 to produce and sell dried cannabis to eligible persons under the Marihuana for Medical Purposes Regulations (MMPR).  Mettrum operates two state-of-the-art indoor facilities in Ontario and recently received approval from Health Canada to increase production capacity by nearly 300 per cent at its Agripharm ("Mettrum Creemore") facility.

"As a pioneering licensed producer in Canada with decades of combined expertise in the agri-pharma, pharmaceutical, distribution and technology industries, Mettrum is well positioned to be at the forefront in the minds of healthcare practitioners and patients who choose medical cannabis to help treat a wide range of medical conditions," said Michael Haines, CEO of Mettrum Health Corp. "Mettrum's current and future activities will always be rooted in our commitment to ongoing research, quality production, superior service and support for Canadian healthcare practitioners and their patients."

In addition to the company's business and production growth, Mettrum continues to develop innovative tools designed for the 1,500+ physicians who have prescribed medical cannabis to Mettrum clients:

 

"The Mettrum Spectrum is an excellent tool to select the strain of medical cannabis that best fits my patients' profiles as it's a simple colour coding system for cannabis, instead of street names I am not comfortable using," said Dr. Andrew B. Cooper MD MHSC FRCPC, Clinical Director, Caledon Medical Cannabinoid Clinic and Adjunct Professor, University of Toronto Department of Anesthesia. "For new patients, the Mettrum Spectrum helps me communicate about medical cannabis and follow the College of Family Physicians Canada's guidelines for prescribing. For patients on an established Cannabinoid therapy, the Mettrum Spectrum helps me titrate the dosage in a straightforward, stepwise manner."  

Mettrum is actively involved in innovative research that contributes to the ongoing study of medical cannabis. One of the company's most recent investments in research includes becoming a key funding partner in the creation of the first registry for medical cannabis patients in the Province of Quebec. This innovative project by the Research Institute of the McGill University Health Centre (RI-MUHC) and the Canadian Consortium for the Investigation of Cannabinoids (CCIC) represents the world's first research database on the use of cannabis for medical purposes and will allow healthcare practitioners to better monitor patient safety.

For more information on Mettrum please visit mettrum.com. Individuals interested in medical cannabis should speak with a Mettrum client service representative at 1-844-METTRUM to obtain information on the process.

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly-owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Marihuana for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "MMPR"), which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis on the same date at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Agripharm's facility in Clearview, Ontario. With the Company's two licenses, Mettrum is a leading producer and vendor of medical marijuana under the MMPR system.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release. 

SOURCE Mettrum Health Corp.

Video with caption: "B-roll: Mettrum Health Corp.'s two state-of-the-art facilities in Bowmanville and Creemore, Ontario produce over 1,200kg of medical cannabis products annually. www.mettrum.com". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20150817_C6739_VIDEO_EN_478606.mp4&posterurl=http%3a%2f%2fphotos.newswire.ca%2fimages%2f20150817_C6739_PHOTO_EN_478606.jpg&order=1&jdd=20150817&cnum=C6739

Image with caption: "Mettrum Health Corp. logo (CNW Group/Mettrum Health Corp.)". Image available at: http://photos.newswire.ca/images/download/20150817_C6739_PHOTO_EN_478270.jpg

Image with caption: "Mettrum Spectrum: Mettrum Health Corp. develops innovative tools designed for the 1,500+ physicians who have prescribed medical cannabis to Mettrum clients. The Mettrum Spectrum is designed to simplify the dialogue around medical cannabis by categorizing Mettrum strains according to THC potency, as well as CBD levels. www.mettrum.com (CNW Group/Mettrum Health Corp.)". Image available at: http://photos.newswire.ca/images/download/20150817_C6739_PHOTO_EN_479042.jpg



For further information: Christina Vanin, High View Communications, christina@highviewcommunications.com, 416-322-5897 ext.221; Brooke Woolnough, High View Communications, brooke@highviewcommunications.com, 416-322-5897 ext. 226


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890